Identification of a Class of WNK Isoform-Specific Inhibitors Through High-Throughput Screening.
Chlebowicz, J., Akella, R., Humphreys, J.M., He, H., Kannangara, A.R., Wei, S., Posner, B., Goldsmith, E.J.(2023) Drug Des Devel Ther 17: 93-105
- PubMed: 36712947 
- DOI: https://doi.org/10.2147/DDDT.S389461
- Primary Citation of Related Structures:  
8EDH - PubMed Abstract: 
WNK [with no lysine (K)] kinases are serine/threonine kinases associated with familial hyperkalemic hypertension (FHHt). WNKs are therapeutic targets for blood pressure regulation, stroke and several cancers including triple negative breast cancer and glioblastoma. Here, we searched for and characterized novel WNK kinase inhibitors.
Organizational Affiliation: 
Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX, USA.